title: Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma.
abstract: This pilot study has compared the polymorphic genotype frequencies of methylenetetrahydrofolate reductase (MTHFR A1298C and C677T), methionine synthase (MTR A2756G), methionine synthase reductase (MTRR A66G), and thymidylate synthase (TS 2R/3R) in 113 patients with sporadic colorectal adenocarcinoma (SCA) and 188 healthy blood donors, used as matched controls. The aim was to assess the role of these genotypes in the increased risk of SCA among the southeastern Brazilian population. Carriers of genotype MTRR 66GG, or the combined variants MTHFR 1298AC + CC plus 677CT + TT, or MTHFR 677CT + TT plus MTR 2756AG + GG, or MTHFR 1298AC + CC plus 677CT + TT plus MTR 2756AG + GG, or yet, MTHFR 1298AC + CC plus 677CT + TT plus MTRR 66AG + GG, respectively, showed an increased risk of the order of 1.99-, 3.26-, 2.22-, 10.92-, and 14.88-fold of developing SCA when compared with carriers of the other studied polymorphic genotypes, whether in isolation or in combination. In addition, individuals with the MTHFR 677CT + TT or the MTR 2756AG + GG genotypes had a 2.12- and a 1.42-fold increased risks of SCA onset before 50 years of age. African-Brazilians with the MTRR 66GG genotype had a 1.98-fold increased risk of SCA while individuals with the MTR 2756AG + GG and the MTHFR 677CT + TT genotypes showed a 2.11- and a 1.62-fold increased risk of undifferentiated and advanced tumors at diagnosis, respectively. Carriers of genotype MTHFR 1298AC + CC or MTHFR 1298AC + CC plus MTRR 66AG + GG had a 1.42- and a 3.07-fold increased risk of rectal tumor, respectively. Additionally, carriers of MTHFR 677CT + TT or MTHFR 677CT + TT plus TS 2R/3R + 3R/3R had a 1.55- and a 5.39-fold increased risk for colon tumor, respectively, in comparison with carriers of the wild genotypes. These data suggest that all polymorphisms coding for folate and methionine-dependent enzymes, particularly when present in combination with other polymorphisms, have consistent roles in the increased risk of SCA among the southeastern population of Brazil.
authors: Service of Oncohematology, Department of Clinical Oncology from Hospital Santa Rita (Complexo Hospitalar Santa Casa), Grupo Hospitalar Conceição, Rua Capitão Pedro Werlang, 614, Partenon, Porto Alegre, Rio Grande do Sul, Cep.: 91530110, Brazil. guimajl@hotmail.com
authors: José Luiz Miranda
authors: JL
authors: Guimarães
authors: Maria de Lurdes
authors: Mde L
authors: Ayrizono
authors: Cláudio Saddy Rodrigues
authors: CS
authors: Coy
authors: Carmen Silvia Passos
authors: CS
authors: Lima
references: Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1611-21
references: 12496052
references: J Hum Genet. 2007;52(1):73-85
references: 17089070
references: Int J Oncol. 2001 Aug;19(2):383-6
references: 11445856
references: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
references: 10411935
references: Cancer Sci. 2004 Nov;95(11):908-13
references: 15546509
references: Blood. 2002 May 15;99(10):3786-91
references: 11986237
references: Am J Pathol. 1996 Oct;149(4):1129-37
references: 8863662
references: Eur J Hum Genet. 2010 Mar;18(3):370-8
references: 19826453
references: Hum Mol Genet. 1996 Dec;5(12):1867-74
references: 8968737
references: Clin Cancer Res. 2003 Feb;9(2):743-8
references: 12576444
references: Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3290-5
references: 9096386
references: Carcinogenesis. 2007 Aug;28(8):1672-9
references: 17449906
references: Cancer Causes Control. 2002 Apr;13(3):239-48
references: 12020105
references: Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):203-8
references: 18712959
references: Am J Hum Genet. 2000 Aug;67(2):444-61
references: 10873790
references: Int J Colorectal Dis. 2010 Feb;25(2):141-51
references: 19669769
references: Hum Genet. 2004 Jan;114(2):182-5
references: 14586640
references: Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1436-43
references: 15342443
references: Gut. 2002 Apr;50(4):520-4
references: 11889073
references: Int J Cancer. 2004 Mar 1;108(6):852-6
references: 14712487
references: Clin Cancer Res. 2001 Dec;7(12):4096-101
references: 11751507
references: J Nutr Biochem. 1999 Feb;10(2):66-88
references: 15539274
references: Int J Colorectal Dis. 2007 Jul;22(7):757-63
references: 17111187
references: Mol Med. 2010 Sep-Oct;16(9-10):425-32
references: 20549016
references: Br J Nutr. 2008 Feb;99(2):379-89
references: 18053312
references: Carcinogenesis. 1997 May;18(5):869-82
references: 9163670
references: Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2408-17
references: 17164363
references: Am J Epidemiol. 2009 Nov 15;170(10):1207-21
references: 19846566
references: Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):513-8
references: 10385141
references: Cell Struct Funct. 1995 Jun;20(3):191-7
references: 7586009
references: Am J Epidemiol. 2004 Mar 1;159(5):423-43
references: 14977639
references: Rev Saude Publica. 2000 Feb;34(1):50-5
references: 10769361
references: Am J Hum Genet. 1998 May;62(5):1044-51
references: 9545395
references: Arch Latinoam Nutr. 1989 Sep;39(3):392-404
references: 2562330
references: Nat Genet. 1995 May;10(1):111-3
references: 7647779
references: Chirurgia (Bucur). 2010 May-Jun;105(3):379-82
references: 20726305
references: Am J Clin Nutr. 1987 May;45(5 Suppl):1226-31
references: 3034045
references: Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2175-80
references: 15598777
references: Asian Pac J Cancer Prev. 2002;3(4):353-359
references: 12716294
references: Cancer Biomark. 2009;5(6):233-40
references: 20037199
references: Rev Assoc Med Bras (1992). 1992 Jul-Sep;38(3):138-44
references: 1340363
references: Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):285-92
references: 14973104
references: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3059-64
references: 9501215